Article Text

other Versions

PDF
Cohort mortality study of workers at seven beryllium processing plants: update and associations with cumulative and maximum exposure
  1. Mary K Schubauer-Berigan,
  2. James R Couch,
  3. Martin R Petersen,
  4. Tania Carreón,
  5. Yan Jin,
  6. James A Deddens
  1. National Institute for Occupational Safety and Health, Division of Surveillance, Hazard Evaluations, and Field Studies, Cincinnati, Ohio, USA
  1. Correspondence to Mary K Schubauer-Berigan, NIOSH, DSHEFS, MS-R15, 4676 Columbia Parkway, Cincinnati, OH 45226, USA; zcg3{at}cdc.gov

Abstract

Objectives To extend follow-up of cause-specific mortality in workers at seven beryllium processing plants and to estimate associations between mortality risk and beryllium exposure.

Methods 9199 workers were followed for mortality from 1940 through 2005. Standardised mortality ratios (SMRs) were estimated based on US population comparisons for lung, nervous system and urinary tract cancers, chronic obstructive pulmonary disease (COPD), chronic kidney disease, and categories containing chronic beryllium disease (CBD) and cor pulmonale. Associations with maximum and cumulative exposure were calculated for a subset of the workers.

Results Overall mortality in the cohort compared with the US population was elevated for lung cancer (SMR 1.17; 95% CI 1.08 to 1.28), COPD (SMR 1.23; 95% CI 1.13 to 1.32), and the categories containing CBD (SMR 7.80; 95% CI 6.26 to 9.60) and cor pulmonale (SMR 1.17; 95% CI 1.08 to 1.26). Mortality rates for most diseases of interest increased with time-since-hire. For the category including CBD, rates were substantially elevated compared to the US population across all exposure groups. Workers whose maximum beryllium exposure was ≥10 μg/m3 had higher rates of lung cancer, urinary tract cancer, COPD and the category containing cor pulmonale than workers with lower exposure. Significant positive trends with cumulative exposure were observed for nervous system cancers (p=0.0006) and, when short-term workers were excluded, lung cancer (p=0.01), urinary tract cancer (p=0.003) and COPD (p<0.0001).

Conclusion These findings reaffirm that lung cancer and CBD, and suggest that COPD and nervous system and urinary tract cancers, are related to beryllium exposure. Cigarette smoking and exposure to other lung carcinogens are unlikely to explain these elevations.

  • Occupational diseases
  • epidemiology
  • lung neoplasms
  • beryllium disease
  • life table analysis
  • cancer
  • mortality studies
  • metals

Statistics from Altmetric.com

Footnotes

  • The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the National Institute for Occupational Safety and Health.

  • Funding The US National Institute for Occupational Safety and Health provided funding for this study.

  • Competing interests None.

  • Ethics approval This study was conducted with the approval of the Human Subjects Review Board of the National Institute for Occupational Safety and Health.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles